2931 — Euglena Co Balance Sheet
0.000.00%
- ¥62bn
- ¥68bn
- ¥48bn
- 47
- 28
- 70
- 47
Annual balance sheet for Euglena Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,254 | 10,186 | 9,954 | 15,791 | 20,631 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,068 | 3,118 | 3,780 | 3,736 | 4,158 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 9,792 | 20,438 | 19,694 | 24,431 | 30,865 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,304 | 6,852 | 5,848 | 5,506 | 6,048 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 15,351 | 61,008 | 57,275 | 59,619 | 73,256 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,160 | 10,634 | 12,276 | 12,271 | 12,811 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,974 | 40,424 | 37,924 | 39,405 | 41,552 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 9,377 | 20,583 | 19,351 | 20,214 | 31,704 |
Total Liabilities & Shareholders' Equity | 15,351 | 61,008 | 57,275 | 59,619 | 73,256 |
Total Common Shares Outstanding |